Prioridades nacionales de investigación en Tuberculosis en Perú 2018-2021

Ministerio de Salud de Peru; Instituto Nacional de Salud.
Lima; Perú. Ministerio de Salud; 20180600. 3 p.
Monografía en Español | MINSAPERU, LILACS | ID: biblio-987348

Documentos relacionados

  1. The importance of adherence in tuberculosis treatment clinical trials and its relevance in explanatory and pragmatic trials.
  2. A Cluster-based Method to Quantify Individual Heterogeneity in Tuberculosis Transmission.
  3. Orthogonal array composite designs for drug combination experiments with applications for tuberculosis.
  4. Determining the minimum duration of treatment in tuberculosis: An order restricted non-inferiority trial design.
  5. [Analysis and Discussion of Problems Founded in Quality Control of Medical Device Clinical Trials].
  6. A Cluster-based Method to Quantify Individual Heterogeneity in Tuberculosis Transmission.
  7. Metabolomics meets systems immunology.
  8. Dose-response prediction for in-vitro drug combination datasets: a probabilistic approach.
  9. CLC Estimator: A Tool for Latent Construct Estimation via Congeneric Approaches in Survey Research.
  10. Adaptive Box-Cox Transformation: A Highly Flexible Feature-Specific Data Transformation to Improve Metabolomic Data Normality for Better Statistical Analysis.